IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Greed Is Good who wrote (223)	2/7/1998 2:34:00 PM
From: Curtis Dean	Read Replies (1) of 1510

Manny, Do you have any feeling as far as the completion of Phase III Remune trial and possible FDA approval? I became aware of IMNR in 1989 when we designed their laboratory facility in Carlsbad, Ca. In 1991 I purchased shares of IMNR at $4/share and sold them the same year at $14, unfortunately I was premature and missed the run up to $60/share at the end of the year. What I don't understand is IMNR began enrolling HIV infected patients in 1987 to test their HIV therapeutic vaccine and their phase III HIV therapeutic vaccine trial was supposed to be completed in 1992. It seems by now they should know if there drug works or not! I recently bought their stock again at $7/share. I am a little nervous though about all the recent insider sales going on, particularly the purchase of cheap options ($2-$3/share) then there immediate sale at $11-$12/share by company insiders. What do you think? and why are you confident Remune actually works? Hope to hear from you. Curtis

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next